A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results